Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.

Exenatide reduces DOX-induced apoptosis of cardiomyocytes by upregulating autophagy and improving cardiac dysfunction. These novel results highlight the therapeutic potential of exenatide to prevent doxorubicin cardiotoxicity.